Age at ASD diagnosis | |
Mean (SD) (range) | 32.2 (19) (11 to 72) |
Median | 28 |
Childhood onset (no.) | 4 |
Disease free interval between childhood and adult symptoms | 1 |
Disease duration (years) | |
Mean (SD) (range) | 8.5 (6) (2 to 21) |
Median | 6.5 |
Age at anti-TNF start (years) | |
Mean (SD) (range) | 40.7 (17) (18 to 74) |
Median | 34.5 |
Predominant clinical expression | |
Chronic arthritis | 15 |
Systemic | 5 |
Symptoms (no.) | |
Fever | 20 |
Arthralgia | 20 |
Polyarthritis | 18 |
Sore throat/pharyngitis | 14 |
Rash | 16 |
Seritis | 4 |
Lymphadenopathy | 6 |
Increased leukocyte level | 20 |
Polymorphonuclear level >10 000 mm3 | 20 |
Abnormal liver function test result | 6 |
High serum ferritin level | 14 |
Disseminated intravascular coagulation syndrome | 5 |
Previous treatments | |
Prednisone | 20 |
Methotrexate | 20 |
Intravenous polyvalent immunoglobulin | 5 |
Sulfasalazine | 2 |
Hydroxychloroquine | 6 |
Gold salts | 2 |
D-Penicillamin | 1 |
Thalidomide | 1 |
Cyclosporine A | 5 |
Cyclophosphamide | 4 |
Azathioprine | 3 |